The pharmaceutical industry in Türkiye saw a market share of 0.26% in its export segment in 2023. Forecast data from 2024 to 2028 indicate modest annual increases, starting at 0.27% in 2024 and potentially reaching 0.29% by 2028.
- Year-on-year variation: 0.27% to 0.28% from 2024 to 2025 (approximately 3.7% increase).
- Year-on-year variation: 0.28% to 0.29% from 2026 to 2027 (approximately 3.6% increase).
- 5-year CAGR: The compound annual growth rate over 5 years indicates a steady average annual increase.
Future trends to watch for include potential impacts from global supply chain shifts, increasing R&D investment in Türkiye, evolving regulatory landscapes, and emerging markets' influence on export dynamics.
